Literature DB >> 27408414

Delayed Serological Transfusion Reaction After Platelet Transfusion Due to Anti-e.

Deepti Sachan1, Aswin Kumar1, Dinesh Jothimani2, Mohamed Rela2.   

Abstract

Delayed serological transfusion reaction (DSTR) is defined as absence of clinical signs of hemolysis and demonstration of new, clinically-significant antibodies against red blood cells after a transfusion, by either positive direct antiglobulin test or positive antibody screen with newly identified RBC alloantibody. Various delayed hemolytic transfusion reaction cases are reported after red cell transfusions. However, the incidence of DSTR after platelet transfusion due to non-Rh(D) antibodies is not much documented. We report here a case of DSTR due to anti-e Rh antibody in a multiply red cell alloimmunized female patient after single donor platelets transfusion.

Entities:  

Keywords:  Anti-e; Delayed serological transfusion reaction; Red cell antibody; Rh alloimmunization

Year:  2016        PMID: 27408414      PMCID: PMC4925546          DOI: 10.1007/s12288-016-0635-5

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  10 in total

Review 1.  Delayed hemolytic transfusion reaction by a Kidd antibody after heart surgery: case report and review of the literature.

Authors:  Vassiliki Kazakou; Alexandra Kousoulakou; Euthemia Melissari
Journal:  J Thorac Cardiovasc Surg       Date:  2007-05       Impact factor: 5.209

2.  Red blood cell alloimmunisation after platelet transfusion: a 5-year study.

Authors:  Pierre Moncharmont; Gregory Barday; Francis Meyer
Journal:  Blood Transfus       Date:  2013-08-08       Impact factor: 3.443

3.  Incidence of Red Cell Alloantibody among the Transfusion Recipients of Universiti Kebangsaan Malaysia Medical Centre.

Authors:  Rabeya Yousuf; Suria Abdul Aziz; Nurasyikin Yusof; Chooi Fun Leong
Journal:  Indian J Hematol Blood Transfus       Date:  2012-04-25       Impact factor: 0.900

4.  Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients.

Authors:  Joan Cid; Gloria Carbassé; Arturo Pereira; Cristina Sanz; Roberto Mazzara; Ginés Escolar; Miguel Lozano
Journal:  Transfusion       Date:  2010-12-03       Impact factor: 3.157

5.  Hemolytic transfusion reactions in oncology patients: experience in a large cancer center.

Authors:  B Lichtiger; E Perry-Thornton
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

6.  Delayed hemolytic transfusion reactions. Evidence of the need for an improved pretransfusion compatibility test.

Authors:  S B Moore; H F Taswell; A A Pineda; C L Sonnenberg
Journal:  Am J Clin Pathol       Date:  1980-07       Impact factor: 2.493

7.  The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance.

Authors:  P M Ness; R S Shirey; S K Thoman; S A Buck
Journal:  Transfusion       Date:  1990-10       Impact factor: 3.157

8.  Fatal delayed hemolytic transfusion reaction due to anti-c + E.

Authors:  N M Hillman
Journal:  Transfusion       Date:  1979 Sep-Oct       Impact factor: 3.157

9.  Non-D Rh antibodies appearing after apheresis platelet transfusion: stimulation by red cells or microparticles?

Authors:  J Kitazawa; K Nollet; H Morioka; K Tanaka; M Inomata; Y Kubuki; H Ohto
Journal:  Vox Sang       Date:  2010-10-28       Impact factor: 2.144

10.  Delayed hemolytic transfusion reaction due to anti-S antibody in patient with anti-Jk(a) autoantibody and multiple alloantibodies.

Authors:  S Guastafierro; F Sessa; C Cuomo; A Tirelli
Journal:  Ann Hematol       Date:  2003-10-14       Impact factor: 3.673

  10 in total
  1 in total

1.  ABO, Rhesus, and Kell Antigens, Alleles, and Haplotypes in West Bengal, India.

Authors:  Debapriya Basu; Suvro Sankha Datta; Celina Montemayor; Prasun Bhattacharya; Krishnendu Mukherjee; Willy A Flegel
Journal:  Transfus Med Hemother       Date:  2017-10-20       Impact factor: 3.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.